Miconazole
- Generic Name
- Miconazole
- Brand Names
- Aloe Vesta Antifungal, Baza, Critic-aid Clear, Desenex, Fungoid, Inzo, Lagicam, Lotrimin AF, Micatin, Micro-guard, Monistat, Monistat 1 Day Ovule Combination Pack, Monistat 3 Day Ovule Combination Pack, Monistat 7 Combination Pack, Oravig, Rash Relief Antifungal, Remedy Antifungal, Tetterine, Tineacide Antifungal, Ting, Vagistat, Vagistat 3 Day Combination Pack, Vusion, Zeasorb
- Drug Type
- Small Molecule
- Chemical Formula
- C18H14Cl4N2O
- CAS Number
- 22916-47-8
- Unique Ingredient Identifier
- 7NNO0D7S5M
- Background
Miconazole is a broad-spectrum azole antifungal with some activity against Gram-positive bacteria as well. It is widely used to treat mucosal yeast infections, including both oral and vaginal infections; although intravenous miconazole is no longer available, a wide variety of suppositories, creams, gels, and tablet-based products are available. Miconazole i...
- Indication
Miconazole is indicated for the local treatment of oropharyngeal candidiasis in adult patients and for the adjunctive treatment of diaper dermatitis complicated by candidiasis in immunocompetent patients aged four weeks and older. Miconazole is available as both a suppository and cream for the treatment of vaginal yeast infections and the relief of associate...
- Associated Conditions
- Acne Vulgaris, Dermatophytosis, Dermatophytosis of nail, Diaper Dermatitis, Excessive sweating and body odor, Fungal skin infection, Gastrointestinal candidiasis, Infection, Mixed, Infections, Fungal of the Skin Folds, Nail candida, Oropharyngeal Candidiasis, Pityriasis versicolor, Ringworm, Seborrheic Dermatitis, Skin candida, Tinea Capitis, Tinea Corporis, Tinea Cruris, Tinea Pedis, Vaginal Candidiasis, Cutaneous candidiasis
- Associated Therapies
- -
Use of Maqui Berry Extract in Treating Oral Candidiasis in Diabetes Mellitus Patients and Systemically Healthy Persons
- Conditions
- Interventions
- First Posted Date
- 2023-06-23
- Last Posted Date
- 2023-06-23
- Lead Sponsor
- University of Belgrade
- Target Recruit Count
- 90
- Registration Number
- NCT05916729
- Locations
- 🇷🇸
Natasa Nikolic Jakoba, Belgrade, Serbia
Clinical Trial Comparing Dapaconazole Versus Miconazole in Patients With Tinea Cruris
- First Posted Date
- 2017-12-02
- Last Posted Date
- 2017-12-02
- Lead Sponsor
- Galeno Desenvolvimento de Pesquisas Clínicas
- Target Recruit Count
- 51
- Registration Number
- NCT03359070
- Locations
- 🇧🇷
Galeno Desenvolvimento de Pesquisas Clinicas Ltda. - ME, Campinas, SP, Brazil
Efficacy of Standardized-propolis Extract (EPP-AF®) Gel Formulation as Buccal Antiseptic
- Conditions
- Interventions
- First Posted Date
- 2016-06-30
- Last Posted Date
- 2016-06-30
- Lead Sponsor
- University of Sao Paulo
- Target Recruit Count
- 40
- Registration Number
- NCT02818803
- Locations
- 🇧🇷
Unidade de Pesquisa Clinica HCRP-USP, Ribeirao Preto, São Paulo, Brazil
🇧🇷Unievangelica Anapolis, Anapolis, Goias, Brazil
DDI Potential: Dapivirine Vaginal Ring and Miconazole Nitrate
- First Posted Date
- 2012-11-22
- Last Posted Date
- 2017-09-08
- Lead Sponsor
- International Partnership for Microbicides, Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT01731574
- Locations
- 🇧🇪
SGS Life Sciences, Lange Beeldekensstraat 267, Antwerpen, Belgium
Clinical Trial of Hydroquinone Versus Miconazol in Melasma
- First Posted Date
- 2012-08-09
- Last Posted Date
- 2014-12-02
- Lead Sponsor
- Universidad Autonoma de San Luis Potosí
- Target Recruit Count
- 60
- Registration Number
- NCT01661556
- Locations
- 🇲🇽
Dermatology Department. Hospital Central "Dr. Ignacio Morones Prieto", San Luis Potosí, Mexico
Effect of Exercise on Spread of the Miconozole Nitrate OVULE in the Vagina
- Conditions
- First Posted Date
- 2005-09-19
- Last Posted Date
- 2011-08-09
- Lead Sponsor
- University of Pennsylvania
- Target Recruit Count
- 12
- Registration Number
- NCT00194324
- Locations
- 🇺🇸
University of Pennsylvania Reproductive Research Unit, Philadelphia, Pennsylvania, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.